NO974400D0 - Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan - Google Patents

Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Info

Publication number
NO974400D0
NO974400D0 NO974400A NO974400A NO974400D0 NO 974400 D0 NO974400 D0 NO 974400D0 NO 974400 A NO974400 A NO 974400A NO 974400 A NO974400 A NO 974400A NO 974400 D0 NO974400 D0 NO 974400D0
Authority
NO
Norway
Prior art keywords
benazeprilat
valsartan
preparations containing
combination preparations
containing benazepril
Prior art date
Application number
NO974400A
Other languages
English (en)
Other versions
NO974400L (no
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO974400L publication Critical patent/NO974400L/no
Publication of NO974400D0 publication Critical patent/NO974400D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO974400A 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan NO974400D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (2)

Publication Number Publication Date
NO974400L NO974400L (no) 1997-09-23
NO974400D0 true NO974400D0 (no) 1997-09-23

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974400A NO974400D0 (no) 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (no)
JP (1) JPH11503139A (no)
KR (1) KR19980703647A (no)
CN (1) CN1181019A (no)
AU (1) AU5399096A (no)
BR (1) BR9604818A (no)
CA (1) CA2214143A1 (no)
CZ (1) CZ313897A3 (no)
HU (1) HUP9801593A2 (no)
MX (1) MX9707683A (no)
NO (1) NO974400D0 (no)
PL (1) PL322529A1 (no)
SK (1) SK133897A3 (no)
TR (1) TR199701121T1 (no)
WO (1) WO1996031234A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU716519B2 (en) * 1995-06-30 2000-02-24 Laboratoires Merck Sharp & Dohme - Chibret Snc Method of treating renal disease using an ace inhibitor and an A II antagonist
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
CZ20023381A3 (cs) * 2000-04-12 2003-02-12 Novartis Ag Kombinované farmaceutické prostředky obsahující antagonistu AT1-receptoru nebo/a inhibitor HMG-CoA reduktázy nebo/a ACE inhibitor
RU2275363C2 (ru) * 2000-07-19 2006-04-27 Новартис Аг Соли валсартана, фармацевтическая композиция на их основе и способ получения солей
MXPA03001509A (es) * 2000-08-22 2003-06-09 Boehringer Ingelheim Pharma Combinacion farmaceutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversion de la angiotensina i.
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
IL156136A0 (en) * 2000-12-18 2003-12-23 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN1465712A (zh) * 2002-07-05 2004-01-07 安徽省生物医学研究所 一种预测acei类降压药药效的试剂盒、方法、软件和复方药
EP1578360A4 (en) * 2002-08-28 2009-10-21 Curis Inc JOINT ADMINISTRATION OF MORPHOGENES AND ANGIOTENSIN ENZYME CONVERTING INHIBITORS FOR THE TREATMENT OF CHRONIC RENAL FAILURE
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
MX346039B (es) 2009-05-20 2017-03-03 Boehringer Ingelheim Vetmedica Gmbh Solucion farmaceutica bebible de telmisartan.
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CA2938406A1 (en) * 2014-01-31 2015-08-06 Janssen Pharmaceutica Nv Methods for the treatment and prevention of renal disorders and fatty liver disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227346B1 (en) * 1990-05-11 2011-04-28 Pfizer Process for producing synergetic pharmaceutical composition
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
CN1181019A (zh) 1998-05-06
EP0820302A1 (en) 1998-01-28
HUP9801593A2 (hu) 1999-01-28
CZ313897A3 (cs) 1998-01-14
KR19980703647A (ko) 1998-12-05
JPH11503139A (ja) 1999-03-23
MX9707683A (es) 1997-12-31
NO974400L (no) 1997-09-23
TR199701121T1 (xx) 1998-03-21
WO1996031234A1 (en) 1996-10-10
CA2214143A1 (en) 1996-10-10
PL322529A1 (en) 1998-02-02
AU5399096A (en) 1996-10-23
SK133897A3 (en) 1998-02-04
BR9604818A (pt) 1998-06-09

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
DE69731559D1 (de) Gesichts- und atemschutzsystem
IS4481A (is) Díhýdrópyramídín og notkun þeirra
NO973216D0 (no) Substituerte oksazolidin-calpain- og/eller cathepsin B-inhibitorer
IL122813A0 (en) Thrombin inhibitors their preparation and use
DK0804078T3 (da) Sammensætning og anvendelse deraf
DK0741005T3 (da) Kompositfilm og anvendelse deraf
NO974400D0 (no) Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan
GB2304309B (en) Laminate and use thereof
FI963334A0 (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
NO960847D0 (no) System med fortöyning og forbindelsesledning
DE69620243D1 (de) Haupt- und nebenstromfilter
FI960270A0 (fi) Parannuksia laivoihin ja niihin liittyen
FR2739382B1 (fr) Fraction ribosomale et composition la contenant
EP0744125A3 (en) Iodine complex and its application
NO995374D0 (no) Ferrosen-dikarboksylsyre-diestere og kompositt-fastdrivstoffer inneholdende disse
KR960029575U (ko) 미아 및 물품분실 방지장치
IL112773A0 (en) Parallel balance systems and improvements to parallel balance systems
EP0777523A4 (en) SELF-EMULSIFYING AND EMOLLIENT AGENTS
HU9500363D0 (en) Personal alarm
KR950027796U (ko) 미서기 창호 구조
NO302753B1 (no) Tetrazolderivater og anvendelse av disse
FI925598A0 (fi) Multiplekseri ja demultiplekseri
FI952222A0 (fi) Foerfarande och anordingar foer att laengsriktat omsluta en metall-ledare med en eller flera isolerfilmer
HU0200089V0 (en) Mammer in case of emergency